Pure Global
NCT05498363

Bacteriophage Therapy of Difficult-to-treat Infections

Bacteriophage Therapy of Difficult-to-treat Infections: a Retrospective, Observational Analysis of the First One Hundred Consecutive Cases Facilitated by a Belgian Consortium
Queen Astrid Military Hospital·ClinicalTrials.gov·biologicalCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bacterial Infections
Drug/Device/Intervention
Bacteriophage therapy
Study type
Observational
Intervention type
biological
Sponsor & location
Primary sponsor
Queen Astrid Military Hospital
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2008
End date
Dec 31, 2021
Enrollment
100 participants
Primary outcome

Clinical improvement,Microbial eradication,Adverse reactions

Summary

A retrospective, observational analysis of the first one hundred consecutive cases of
 bacteriophage therapy of difficult-to-treat infections, facilitated by a Belgian consortium.

ICD-10 classifications
Bacterial infection, unspecifiedBacterial, viral and other infectious agentsOther bacterial intestinal infectionsOther bacterial diseasesOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05498363
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05498363 through Pure Global AI's free database. This phase not specified trial is sponsored by Queen Astrid Military Hospital and is currently Completed. The study focuses on Bacterial Infections. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.